25 XP   0   0   10

Vigil Neuroscience Inc
Buy, Hold or Sell?

Let's analyze Vigil Neuroscience Inc together

I guess you are interested in Vigil Neuroscience Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vigil Neuroscience Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Vigil Neuroscience Inc

I send you an email if I find something interesting about Vigil Neuroscience Inc.

Quick analysis of Vigil Neuroscience Inc (30 sec.)










What can you expect buying and holding a share of Vigil Neuroscience Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$2.60
Expected worth in 1 year
$0.76
How sure are you?
18.2%

+ What do you gain per year?

Total Gains per Share
$-1.84
Return On Investment
-46.6%

For what price can you sell your share?

Current Price per Share
$3.95
Expected price per share
$2.47 - $5.3
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

1. Valuation of Vigil Neuroscience Inc (5 min.)




Live pricePrice per Share (EOD)

$3.95

2. Growth of Vigil Neuroscience Inc (5 min.)




Is Vigil Neuroscience Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$103.7m$179.2m-$51.8m-40.7%

How much money is Vigil Neuroscience Inc making?

Current yearPrevious yearGrowGrow %
Making money-$20.6m-$9.6m-$11m-53.2%
Net Profit Margin-286.6%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Vigil Neuroscience Inc (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#355 / 966

Most Revenue
#564 / 966

Most Profit
#710 / 966

Most Efficient
#586 / 966
3rd party ad coffee SUPPORTERis ad-free.

What can you expect buying and holding a share of Vigil Neuroscience Inc? (5 min.)

Welcome investor! Vigil Neuroscience Inc's management wants to use your money to grow the business. In return you get a share of Vigil Neuroscience Inc.

What can you expect buying and holding a share of Vigil Neuroscience Inc?

First you should know what it really means to hold a share of Vigil Neuroscience Inc. And how you can make/lose money.

Speculation

The Price per Share of Vigil Neuroscience Inc is $3.95. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vigil Neuroscience Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vigil Neuroscience Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $2.60. Based on the TTM, the Book Value Change Per Share is $-0.46 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vigil Neuroscience Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.50-12.7%-0.53-13.4%-0.48-12.1%-0.46-11.7%-0.46-11.7%
Usd Book Value Change Per Share-0.39-9.9%-0.46-11.7%0.010.1%0.246.0%0.246.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.39-9.9%-0.46-11.7%0.010.1%0.246.0%0.246.0%
Usd Price Per Share3.41-5.40-8.49-5.69-5.69-
Price to Earnings Ratio-1.70--2.56--4.40--2.92--2.92-
Price-to-Total Gains Ratio-8.74--11.71--10.77--9.87--9.87-
Price to Book Ratio1.31-1.59-1.76-1.36-1.36-
Price-to-Total Gains Ratio-8.74--11.71--10.77--9.87--9.87-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share3.95
Number of shares253
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.460.24
Usd Total Gains Per Share-0.460.24
Gains per Quarter (253 shares)-116.4959.88
Gains per Year (253 shares)-465.95239.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-466-4760240230
20-932-9420479470
30-1398-14080719710
40-1864-18740958950
50-2330-2340011981190
60-2796-2806014371430
70-3262-3272016771670
80-3728-3738019161910
90-4194-4204021562150
100-4659-4670023952390

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.011.00.00.0%0.011.00.00.0%0.011.00.00.0%0.011.00.00.0%
Book Value Change Per Share0.04.00.00.0%2.09.00.018.2%2.09.00.018.2%2.09.00.018.2%2.09.00.018.2%
Dividend per Share0.00.04.00.0%0.00.011.00.0%0.00.011.00.0%0.00.011.00.0%0.00.011.00.0%
Total Gains per Share0.04.00.00.0%2.09.00.018.2%2.09.00.018.2%2.09.00.018.2%2.09.00.018.2%
3rd party ad coffee SUPPORTERis ad-free.

Fundamentals of Vigil Neuroscience Inc

About Vigil Neuroscience Inc

Vigil Neuroscience, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. Its lead candidate is VGL101(Iluzanebart), a human monoclonal antibody agonist targeting human triggering receptor expressed on myeloid cells 2 and is in a Phase 2 trial in patients with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The company is also developing VG-3927, an orally-available small molecule TREM2 agonist to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer's disease in genetically defined subpopulations, which is being evaluated in a Phase 1 clinical trial. It has license agreement with Amgen Inc. to commercially develop, manufacture, use, distribute, and sell therapeutic products containing compounds that bind to TREM2. The company was incorporated in 2020 and is headquartered in Watertown, Massachusetts.

Fundamental data was last updated by Penke on 2024-06-16 09:57:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

1.1. Profitability of Vigil Neuroscience Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vigil Neuroscience Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vigil Neuroscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-286.6%+286.6%
TTM-286.6%YOY--286.6%
TTM-286.6%5Y-104.2%-182.4%
5Y-104.2%10Y-104.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--168.0%+168.0%
TTM-286.6%-209.9%-76.7%
YOY--242.3%+242.3%
5Y-104.2%-401.7%+297.5%
10Y-104.2%-532.2%+428.0%
1.1.2. Return on Assets

Shows how efficient Vigil Neuroscience Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • -15.9% Return on Assets means that Vigil Neuroscience Inc generated $-0.16 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vigil Neuroscience Inc:

  • The MRQ is -15.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -14.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.9%TTM-14.0%-1.9%
TTM-14.0%YOY-5.4%-8.7%
TTM-14.0%5Y-9.9%-4.2%
5Y-9.9%10Y-9.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-15.9%-11.9%-4.0%
TTM-14.0%-11.9%-2.1%
YOY-5.4%-11.3%+5.9%
5Y-9.9%-13.5%+3.6%
10Y-9.9%-14.9%+5.0%
1.1.3. Return on Equity

Shows how efficient Vigil Neuroscience Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • -19.2% Return on Equity means Vigil Neuroscience Inc generated $-0.19 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vigil Neuroscience Inc:

  • The MRQ is -19.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -16.6%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-19.2%TTM-16.6%-2.6%
TTM-16.6%YOY-5.8%-10.9%
TTM-16.6%5Y-9.0%-7.6%
5Y-9.0%10Y-9.0%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-19.2%-14.2%-5.0%
TTM-16.6%-15.7%-0.9%
YOY-5.8%-14.3%+8.5%
5Y-9.0%-19.2%+10.2%
10Y-9.0%-19.7%+10.7%
3rd party ad coffee SUPPORTERis ad-free.

1.2. Operating Efficiency of Vigil Neuroscience Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vigil Neuroscience Inc is operating .

  • Measures how much profit Vigil Neuroscience Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vigil Neuroscience Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-308.4%+308.4%
TTM-308.4%YOY--308.4%
TTM-308.4%5Y-112.1%-196.2%
5Y-112.1%10Y-112.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--354.6%+354.6%
TTM-308.4%-225.9%-82.5%
YOY--252.2%+252.2%
5Y-112.1%-428.3%+316.2%
10Y-112.1%-531.1%+419.0%
1.2.2. Operating Ratio

Measures how efficient Vigil Neuroscience Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Vigil Neuroscience Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM3.084-3.084
TTM3.084YOY-+3.084
TTM3.0845Y1.121+1.962
5Y1.12110Y1.1210.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.004-3.004
TTM3.0843.332-0.248
YOY-3.502-3.502
5Y1.1215.271-4.150
10Y1.1216.915-5.794
3rd party ad coffee SUPPORTERis ad-free.

1.3. Liquidity of Vigil Neuroscience Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vigil Neuroscience Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 12.38 means the company has $12.38 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Vigil Neuroscience Inc:

  • The MRQ is 12.384. The company is very able to pay all its short-term debts. +2
  • The TTM is 13.924. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ12.384TTM13.924-1.539
TTM13.924YOY21.082-7.158
TTM13.9245Y17.034-3.110
5Y17.03410Y17.0340.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ12.3843.767+8.617
TTM13.9244.000+9.924
YOY21.0824.905+16.177
5Y17.0345.883+11.151
10Y17.0346.286+10.748
1.3.2. Quick Ratio

Measures if Vigil Neuroscience Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • A Quick Ratio of 17.79 means the company can pay off $17.79 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vigil Neuroscience Inc:

  • The MRQ is 17.787. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 21.780. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ17.787TTM21.780-3.993
TTM21.780YOY22.432-0.652
TTM21.7805Y20.216+1.564
5Y20.21610Y20.2160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ17.7873.054+14.733
TTM21.7803.506+18.274
YOY22.4324.756+17.676
5Y20.2165.757+14.459
10Y20.2166.338+13.878
3rd party ad coffee SUPPORTERis ad-free.

1.4. Solvency of Vigil Neuroscience Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vigil Neuroscience Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vigil Neuroscience Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.17 means that Vigil Neuroscience Inc assets are financed with 17.0% credit (debt) and the remaining percentage (100% - 17.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vigil Neuroscience Inc:

  • The MRQ is 0.170. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.154. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.170TTM0.154+0.017
TTM0.154YOY0.064+0.089
TTM0.1545Y0.372-0.218
5Y0.37210Y0.3720.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1700.330-0.160
TTM0.1540.342-0.188
YOY0.0640.287-0.223
5Y0.3720.368+0.004
10Y0.3720.382-0.010
1.4.2. Debt to Equity Ratio

Measures if Vigil Neuroscience Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 20.5% means that company has $0.21 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vigil Neuroscience Inc:

  • The MRQ is 0.205. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.182. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.205TTM0.182+0.023
TTM0.182YOY0.069+0.113
TTM0.1825Y0.095+0.087
5Y0.09510Y0.0950.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2050.365-0.160
TTM0.1820.415-0.233
YOY0.0690.370-0.301
5Y0.0950.443-0.348
10Y0.0950.476-0.381
3rd party ad coffee SUPPORTERis ad-free.

2. Market Valuation of Vigil Neuroscience Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Vigil Neuroscience Inc generates.

  • Above 15 is considered overpriced but always compare Vigil Neuroscience Inc to the Biotechnology industry mean.
  • A PE ratio of -1.70 means the investor is paying $-1.70 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vigil Neuroscience Inc:

  • The EOD is -1.974. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.704. Based on the earnings, the company is expensive. -2
  • The TTM is -2.560. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.974MRQ-1.704-0.270
MRQ-1.704TTM-2.560+0.855
TTM-2.560YOY-4.398+1.838
TTM-2.5605Y-2.922+0.362
5Y-2.92210Y-2.9220.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.974-2.341+0.367
MRQ-1.704-2.997+1.293
TTM-2.560-2.882+0.322
YOY-4.398-3.553-0.845
5Y-2.922-6.262+3.340
10Y-2.922-6.288+3.366
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vigil Neuroscience Inc:

  • The EOD is -1.799. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.553. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.137. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.799MRQ-1.553-0.246
MRQ-1.553TTM-3.137+1.584
TTM-3.137YOY-4.510+1.373
TTM-3.1375Y-3.109-0.028
5Y-3.10910Y-3.1090.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-1.799-2.932+1.133
MRQ-1.553-3.739+2.186
TTM-3.137-3.776+0.639
YOY-4.510-4.917+0.407
5Y-3.109-7.942+4.833
10Y-3.109-8.503+5.394
3rd party ad coffee SUPPORTERis ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vigil Neuroscience Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.31 means the investor is paying $1.31 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Vigil Neuroscience Inc:

  • The EOD is 1.517. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.310. Based on the equity, the company is underpriced. +1
  • The TTM is 1.585. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.517MRQ1.310+0.207
MRQ1.310TTM1.585-0.275
TTM1.585YOY1.763-0.178
TTM1.5855Y1.362+0.223
5Y1.36210Y1.3620.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.5171.843-0.326
MRQ1.3102.249-0.939
TTM1.5852.301-0.716
YOY1.7632.412-0.649
5Y1.3623.782-2.420
10Y1.3624.212-2.850
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Vigil Neuroscience Inc.

3.1. Institutions holding Vigil Neuroscience Inc

Institutions are holding 88.71% of the shares of Vigil Neuroscience Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Northpond Ventures, LLC11.213467.7766421449800
2024-03-31Bvf Inc4.82550.17181363300
2023-12-31Artal Group S A4.8190.20351811191-96944-5.0806
2024-03-31Sphera Funds Management Ltd.4.60410.829117304141195294223.3693
2024-03-31Deep Track Capital, LP4.24360.1558159493100
2024-03-31683 Capital Management LLC2.64710.24839949009949000
2024-03-31Vanguard Group Inc2.37990.00018944739527611.9215
2024-03-31BlackRock Inc2.33350.0001877032-42100-4.5804
2023-12-31Pivotal bioVenture Partners Investment Advisor LLC1.49160.480756059500
2024-03-31Rock Springs Capital Management LP1.25570.040947195800
2024-03-31Orbimed Advisors, LLC1.19440.02844889100
2024-03-31Geode Capital Management, LLC0.88930.0001334242187045.9277
2024-03-31ArrowMark Colorado Holdings, LLC (ArrowMark Partners)0.77020.011128946000
2024-03-31State Street Corporation0.7611028606327720.9785
2024-03-31Ensign Peak Advisors Inc0.60840.001422867400
2023-12-31Anson Funds Management LP0.55080.08652070162070160
2023-12-31Trustees Of Columbia University In The City Of New York0.51341.376519297300
2024-03-31Northern Trust Corp0.36910.0001138720-2681-1.896
2024-03-31Barclays PLC0.30080.0001113036-10759-8.691
2023-12-31Goldman Sachs Group Inc0.22640.000185100-61102-41.7929
Total 45.997371.40917287800+2300376+13.3%

3.2. Funds holding Vigil Neuroscience Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-04-30Vanguard Total Stock Mkt Idx Inv1.650.000162014000
2024-05-30iShares Russell 2000 ETF0.93360.001935088126840.7708
2024-04-30Vanguard Institutional Extnd Mkt Idx Tr0.45290.000517023800
2024-03-31Fidelity Small Cap Index0.42180.00215852542852.7781
2024-05-30iShares Russell 2000 Value ETF0.35250.0037132499-176-0.1327
2024-04-30State St Russell Sm/Mid Cp® Indx NL Cl C0.26820.000710080000
2024-04-30Fidelity Extended Market Index0.19160.000572008-653-0.8987
2024-04-30Vanguard Russell 2000 ETF0.15980.0017600712080.3475
2024-05-31State St Russell Sm Cap® Indx SL Cl I0.15590.0025860000
2024-03-31Bridgeway Ultra-Small Company Market0.13320.088650064-75000-59.9693
2023-12-31NT R2000 Value Index Fund - NL0.11290.003842426-6831-13.8681
2024-03-31NT R2000 Index Fund - NL0.11170.001941981-144-0.3418
2024-04-30Schwab Small Cap Index0.09770.00173673300
2024-05-30iShares Micro-Cap ETF0.09340.013335099-488-1.3713
2024-03-31NT R2000 Index Fund - DC - NL - 20.08870.0019333391650.4974
2024-03-31Northern Trust Russell 2000 Value Index0.08150.0043064600
2023-12-31NT R2000 Value Index Fund - L0.08150.0043064600
2024-04-30Fidelity Total Market Index0.07420.00012787900
2024-04-30iShares Russell 2000 Small-Cap Idx Instl0.06780.00142549700
2024-03-31Russell 2000 Index Non-Lendable Fund E0.06560.0016246721590.6486
Total 5.59450.13542102744-75791-3.6%

3.3. Insider Transactions

Insiders are holding 9.102% of the shares of Vigil Neuroscience Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-11-20Ivana Magovcevic-liebischBUY40003.75
3rd party ad coffee SUPPORTERis ad-free.

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Vigil Neuroscience Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.390-0.460+18%0.006-6714%0.237-265%0.237-265%
Book Value Per Share--2.6033.269-20%4.711-45%2.997-13%2.997-13%
Current Ratio--12.38413.924-11%21.082-41%17.034-27%17.034-27%
Debt To Asset Ratio--0.1700.154+11%0.064+166%0.372-54%0.372-54%
Debt To Equity Ratio--0.2050.182+13%0.069+196%0.095+116%0.095+116%
Dividend Per Share----0%-0%-0%-0%
Eps---0.500-0.530+6%-0.478-4%-0.461-8%-0.461-8%
Free Cash Flow Per Share---0.549-0.449-18%-0.462-16%-0.445-19%-0.445-19%
Free Cash Flow To Equity Per Share---0.419-0.412-2%0.012-3661%0.172-344%0.172-344%
Gross Profit Margin--1.0061.003+0%1.000+1%1.001+0%1.001+0%
Market Cap148457985.000+8%135936618.510209937147.495-35%324335007.870-58%218300568.224-38%218300568.224-38%
Net Profit Margin----2.8660%-0%-1.0420%-1.0420%
Operating Margin----3.0840%-0%-1.1210%-1.1210%
Operating Ratio---3.084-100%-0%1.121-100%1.121-100%
Pb Ratio1.517+14%1.3101.585-17%1.763-26%1.362-4%1.362-4%
Pe Ratio-1.974-16%-1.704-2.560+50%-4.398+158%-2.922+71%-2.922+71%
Price Per Share3.950+14%3.4105.395-37%8.493-60%5.689-40%5.689-40%
Price To Free Cash Flow Ratio-1.799-16%-1.553-3.137+102%-4.510+190%-3.109+100%-3.109+100%
Price To Total Gains Ratio-10.120-16%-8.737-11.711+34%-10.766+23%-9.865+13%-9.865+13%
Quick Ratio--17.78721.780-18%22.432-21%20.216-12%20.216-12%
Return On Assets---0.159-0.140-12%-0.054-66%-0.099-38%-0.099-38%
Return On Equity---0.192-0.166-13%-0.058-70%-0.090-53%-0.090-53%
Total Gains Per Share---0.390-0.460+18%0.006-6714%0.237-265%0.237-265%
Usd Book Value--103782000.000127426500.000-19%179239750.000-42%115103818.182-10%115103818.182-10%
Usd Book Value Change Per Share---0.390-0.460+18%0.006-6714%0.237-265%0.237-265%
Usd Book Value Per Share--2.6033.269-20%4.711-45%2.997-13%2.997-13%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.500-0.530+6%-0.478-4%-0.461-8%-0.461-8%
Usd Free Cash Flow---21881000.000-17560000.000-20%-17615500.000-19%-17049272.727-22%-17049272.727-22%
Usd Free Cash Flow Per Share---0.549-0.449-18%-0.462-16%-0.445-19%-0.445-19%
Usd Free Cash Flow To Equity Per Share---0.419-0.412-2%0.012-3661%0.172-344%0.172-344%
Usd Market Cap148457985.000+8%135936618.510209937147.495-35%324335007.870-58%218300568.224-38%218300568.224-38%
Usd Price Per Share3.950+14%3.4105.395-37%8.493-60%5.689-40%5.689-40%
Usd Profit---19940000.000-20695750.000+4%-9691500.000-51%-14600909.091-27%-14600909.091-27%
Usd Revenue---483500.000-100%-0%175818.182-100%175818.182-100%
Usd Total Gains Per Share---0.390-0.460+18%0.006-6714%0.237-265%0.237-265%
 EOD+5 -3MRQTTM+12 -20YOY+4 -265Y+6 -2610Y+6 -26

4.2. Fundamental Score

Let's check the fundamental score of Vigil Neuroscience Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.974
Price to Book Ratio (EOD)Between0-11.517
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than117.787
Current Ratio (MRQ)Greater than112.384
Debt to Asset Ratio (MRQ)Less than10.170
Debt to Equity Ratio (MRQ)Less than10.205
Return on Equity (MRQ)Greater than0.15-0.192
Return on Assets (MRQ)Greater than0.05-0.159
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Vigil Neuroscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.660
Ma 20Greater thanMa 504.147
Ma 50Greater thanMa 1003.549
Ma 100Greater thanMa 2003.351
OpenGreater thanClose4.040
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2024-03-31. Currency in USD. All numbers in thousands.

Summary
Total Assets125,078
Total Liabilities21,296
Total Stockholder Equity103,782
 As reported
Total Liabilities 21,296
Total Stockholder Equity+ 103,782
Total Assets = 125,078

Assets

Total Assets125,078
Total Current Assets106,543
Long-term Assets18,535
Total Current Assets
Cash And Cash Equivalents 51,761
Short-term Investments 49,884
Net Receivables 1,495
Other Current Assets 3,403
Total Current Assets  (as reported)106,543
Total Current Assets  (calculated)106,543
+/-0
Long-term Assets
Property Plant Equipment 17,482
Long-term Assets Other 126
Long-term Assets  (as reported)18,535
Long-term Assets  (calculated)17,608
+/- 927

Liabilities & Shareholders' Equity

Total Current Liabilities8,603
Long-term Liabilities12,693
Total Stockholder Equity103,782
Total Current Liabilities
Short-term Debt 937
Accounts payable 1,491
Other Current Liabilities 6,175
Total Current Liabilities  (as reported)8,603
Total Current Liabilities  (calculated)8,603
+/-0
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt12,693
Long-term Liabilities  (as reported)12,693
Long-term Liabilities  (calculated)12,693
+/-0
Total Stockholder Equity
Common Stock4
Retained Earnings -242,712
Accumulated Other Comprehensive Income -30
Other Stockholders Equity 346,520
Total Stockholder Equity (as reported)103,782
Total Stockholder Equity (calculated)103,782
+/-0
Other
Capital Stock4
Cash and Short Term Investments 101,645
Common Stock Shares Outstanding 39,864
Liabilities and Stockholders Equity 125,078
Net Debt -38,131
Net Invested Capital 103,782
Net Working Capital 97,940
Property Plant and Equipment Gross 17,482
Short Long Term Debt Total 13,630



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
0
0
0
0
114,415
102,441
172,812
157,928
215,509
200,393
192,361
175,409
159,156
140,858
125,078
125,078140,858159,156175,409192,361200,393215,509157,928172,812102,441114,4150000
   > Total Current Assets 
0
0
33,538
33,538
111,906
97,483
170,425
155,741
212,938
197,805
172,216
155,719
139,847
121,907
106,543
106,543121,907139,847155,719172,216197,805212,938155,741170,42597,483111,90633,53833,53800
       Cash And Cash Equivalents 
0
0
0
0
110,656
91,420
163,324
148,912
203,863
186,605
95,618
58,741
56,794
51,992
51,761
51,76151,99256,79458,74195,618186,605203,863148,912163,32491,420110,6560000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
68,862
91,423
76,849
65,948
49,884
49,88465,94876,84991,42368,8620000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
15
0
0
604
1,485
1,495
1,4951,4856040015000000000
       Other Current Assets 
0
0
53
53
225
466
468
1,221
702
628
1,359
1,178
1,123
2,482
3,403
3,4032,4821,1231,1781,3596287021,221468466225535300
   > Long-term Assets 
0
0
0
0
2,509
4,958
2,387
2,187
2,571
2,588
20,145
19,690
19,309
18,951
18,535
18,53518,95119,30919,69020,1452,5882,5712,1872,3874,9582,5090000
       Property Plant Equipment 
0
0
635
635
655
1,274
1,344
1,231
1,451
1,395
19,218
18,763
18,382
17,941
17,482
17,48217,94118,38218,76319,2181,3951,4511,2311,3441,27465563563500
       Other Assets 
0
0
37
37
1,854
3,684
1,043
0
1,120
1,193
0
927
0
0
0
00092701,1931,12001,0433,6841,854373700
> Total Liabilities 
0
0
0
0
171,673
171,884
6,634
7,302
9,597
11,312
21,021
21,573
23,320
24,606
21,296
21,29624,60623,32021,57321,02111,3129,5977,3026,634171,884171,6730000
   > Total Current Liabilities 
0
0
8,773
8,773
9,601
9,881
6,599
7,294
9,597
11,312
7,391
8,167
10,142
11,661
8,603
8,60311,66110,1428,1677,39111,3129,5977,2946,5999,8819,6018,7738,77300
       Short-term Debt 
0
0
0
0
360
873
734
541
381
176
1,060
804
874
905
937
9379058748041,0601763815417348733600000
       Accounts payable 
0
0
4,273
4,273
5,104
3,977
2,713
1,732
2,363
1,942
2,166
2,362
1,302
1,946
1,491
1,4911,9461,3022,3622,1661,9422,3631,7322,7133,9775,1044,2734,27300
       Other Current Liabilities 
0
0
148
148
63
116
3,152
5,021
6,853
9,194
4,165
217
98
8,810
6,175
6,1758,810982174,1659,1946,8535,0213,1521166314814800
   > Long-term Liabilities 
0
0
0
0
162,072
162,003
35
8
2,744
2,118
13,630
13,406
13,178
12,945
12,693
12,69312,94513,17813,40613,6302,1182,744835162,003162,0720000
       Deferred Long Term Liability 
0
0
0
0
911
2,757
116
29
193
0
0
0
0
0
0
000000193291162,7579110000
> Total Stockholder Equity
0
0
0
0
-57,258
-69,443
166,178
150,626
205,912
189,081
171,340
153,836
135,836
116,252
103,782
103,782116,252135,836153,836171,340189,081205,912150,626166,178-69,443-57,2580000
   Common Stock
0
0
1
1
1
0
3
3
4
4
4
4
4
4
4
444444433011100
   Retained Earnings Total Equity0000-159,929-140,134-121,678-104,1780000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
-172,812
0
0
0
106
-70
-56
-5
-30
-30-5-56-70106000-172,812000000
   Capital Surplus 
0
0
0
0
0
0
0
254,801
327,586
329,211
331,159
0
0
0
0
0000331,159329,211327,586254,8010000000
   Treasury Stock000000000000000
   Other Stockholders Equity 
0
0
0
0
1,586
2,386
253,338
96,873
112,077
329,211
331,159
334,005
336,486
339,025
346,520
346,520339,025336,486334,005331,159329,211112,07796,873253,3382,3861,5860000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-399
Gross Profit-399-399
 
Operating Income (+$)
Gross Profit-399
Operating Expense-88,467
Operating Income-88,866-88,866
 
Operating Expense (+$)
Research Development60,934
Selling General Administrative27,932
Selling And Marketing Expenses399
Operating Expense88,46789,265
 
Net Interest Income (+$)
Interest Income4,986
Interest Expense-0
Other Finance Cost-0
Net Interest Income4,986
 
Pretax Income (+$)
Operating Income-88,866
Net Interest Income4,986
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-82,638-95,094
EBIT - interestExpense = -88,866
-82,638
-82,638
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-88,866-82,638
Earnings Before Interest and Taxes (EBITDA)-88,467
 
After tax Income (+$)
Income Before Tax-82,638
Tax Provision-0
Net Income From Continuing Ops-78,920-82,638
Net Income-82,638
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses88,866
Total Other Income/Expenses Net6,228-4,986
 

Technical Analysis of Vigil Neuroscience Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vigil Neuroscience Inc. The general trend of Vigil Neuroscience Inc is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vigil Neuroscience Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vigil Neuroscience Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 4.685 < 4.87 < 5.3.

The bearish price targets are: 3.51 > 2.5 > 2.47.

Tweet this
Vigil Neuroscience Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vigil Neuroscience Inc. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vigil Neuroscience Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vigil Neuroscience Inc. The current macd is 0.13161986.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vigil Neuroscience Inc price going down in the near term. -2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Vigil Neuroscience Inc. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Vigil Neuroscience Inc price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Vigil Neuroscience Inc Daily Moving Average Convergence/Divergence (MACD) ChartVigil Neuroscience Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vigil Neuroscience Inc. The current adx is 27.38.

The long score for the Directional Movement Index (DMI) is 3/7.
The longshort score for the Directional Movement Index (DMI) is 3/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Vigil Neuroscience Inc shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bullish trend. The ADX is declining, the bullish trend is weakening. Could be a potential reversal to the downside. +2
Vigil Neuroscience Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vigil Neuroscience Inc. The current sar is 5.76889807.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Vigil Neuroscience Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vigil Neuroscience Inc. The current rsi is 50.66. The current phase is Continuation in bull market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Continuation in bull market: Uptrend continues after a consolidation or pullback. Hold or add to existing positions.
  • Trending down: The RSI is trending down. -1
Vigil Neuroscience Inc Daily Relative Strength Index (RSI) ChartVigil Neuroscience Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vigil Neuroscience Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vigil Neuroscience Inc price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Vigil Neuroscience Inc Daily Stochastic Oscillator ChartVigil Neuroscience Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vigil Neuroscience Inc. The current cci is -35.2881193.

Vigil Neuroscience Inc Daily Commodity Channel Index (CCI) ChartVigil Neuroscience Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vigil Neuroscience Inc. The current cmo is -2.62024965.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Vigil Neuroscience Inc Daily Chande Momentum Oscillator (CMO) ChartVigil Neuroscience Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vigil Neuroscience Inc. The current willr is -65.35433071.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vigil Neuroscience Inc is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vigil Neuroscience Inc Daily Williams %R ChartVigil Neuroscience Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vigil Neuroscience Inc.

Vigil Neuroscience Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vigil Neuroscience Inc. The current atr is 0.51432788.

Vigil Neuroscience Inc Daily Average True Range (ATR) ChartVigil Neuroscience Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vigil Neuroscience Inc. The current obv is 12,573,757.

Vigil Neuroscience Inc Daily On-Balance Volume (OBV) ChartVigil Neuroscience Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vigil Neuroscience Inc. The current mfi is 81.16.

The long score for the Money Flow Index (MFI) is 2/2.
The longshort score for the Money Flow Index (MFI) is 2/(-2 +2).

  • MFI > 50: +1
  • MFI > 80: +1
Vigil Neuroscience Inc Daily Money Flow Index (MFI) ChartVigil Neuroscience Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vigil Neuroscience Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-02-13STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-15STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-16STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-21CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-27WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-13CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-14BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-09DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-10CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-05-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-03MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-07WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-05-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-09STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-13STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-05-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-21MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-05-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-05-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-05-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-05-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-03STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-04BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-06-05STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-06-07STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-06-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-06-14MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-06-18CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-06-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-06-25SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-06-26WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-06-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-02STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside

6.3. Candlestick Patterns

Vigil Neuroscience Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vigil Neuroscience Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5050.660
Ma 20Greater thanMa 504.147
Ma 50Greater thanMa 1003.549
Ma 100Greater thanMa 2003.351
OpenGreater thanClose4.040
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vigil Neuroscience Inc with someone you think should read this too:
  • Are you bullish or bearish on Vigil Neuroscience Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vigil Neuroscience Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vigil Neuroscience Inc

I send you an email if I find something interesting about Vigil Neuroscience Inc.


Stay informed about Vigil Neuroscience Inc.

Receive notifications about Vigil Neuroscience Inc in your mailbox!